September 30, 2010
1:00 - 2:30 pm EST
Sponsored by ClearTrial
Click here to view recorded Webcast
Course Description:
Accurately gauging costs and resource demand for a clinical trial – both internal and outsourced – remains one of the most important challenges for biopharmaceutical companies. This symposium presents new findings from Tufts Center for the Study of Drug Development on this critical topic, as well as examples of how leading biopharmaceutical companies are increasing speed and accuracy in their clinical trial planning and forecasting.
Learning Objectives:
Examine new Tufts research into current industry practices and emerging trends for measuring internal and outsourced costs
Explore industry case studies on:
sharply reducing study planning cycle-times
accelerating delivery of achievable study budgets
gaining greater visibility and control over outsourced costs
Who Should Attend:
VP/Director of Clinical Development
VP/Director of Clinical Operations
VP/Director of Clinical Outsourcing
VP/Director of R&D Finance
VP/Director of Portfolio/Program Management
Chairperson:
Micah Lieberman, Executive Director, Conferences, Cambridge Healthtech Institute (CHI)
Instructors:
Ken Getz, Senior Research Fellow, Tufts Center for the Study of Drug Development
Kristin Mauri, Director, Clinical Services, ClearTrial